Real-World Efficacy of Intravitreal Faricimab for Diabetic Macular Edema: A Systematic Review

Keyphrases

• Diabetic Macular Edema 100%
• Intravitreal 100%
• Real-world Effectiveness 100%
• Faricimab 100%
• Previously Treated 60%
• Treatment Duration 40%
• Nave 40%
• Anti-vascular Endothelial Growth Factor Therapy 40%
• Clinical Outcomes 20%
• Best-corrected Visual Acuity 20%
• Macular Thickness 20%
• Data Extraction 20%
• Anti-vascular Endothelial Growth Factor (anti-VEGF) 20%
• Summarized Data 20%
• Extended Treatment 20%
• Bispecific 20%
• Angiopoietin-2 20%
• Burden of Therapy 20%
• Exudative Maculopathy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetic Macular Edema 100%
• Faricimab 100%
• Vasculotropin 60%
• Retina Maculopathy 20%
• Angiopoietin 2 20%